India’s Top Regulator ‘Relieved Of Post’; Temporary Head In Place
Executive Summary
India has appointed a temporary head for its Central Drugs Standard Control Organization, after terminating GN Singh’s position.
You may also be interested in...
India’s Pricing Authority Head Shunted Out?
India’s firebrand pharma pricing authority chief has been transferred out amid sharply polarized views on either side of the debate around his controversial stint.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.